Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nuclear Export01:42

Nuclear Export

4.7K
The nucleus restricts several proteins within and allows others to pass. The restricted proteins possess a nuclear retention sequence or NRS, anchoring them to the nuclear lamins and preventing their transport to the cytosol. The non-restricted proteins, after their synthesis, are transported to their site of action, such as the cytosol or other organelles, with the help of nuclear export signals or NES.
NES are of three types- the canonical 10-residue long leucine-rich signal and other...
4.7K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.6K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.6K
Nuclear Protein Sorting01:34

Nuclear Protein Sorting

6.1K
Nuclear protein sorting is the selective trafficking of histones, polymerases, gene regulatory proteins into the nucleus and exporting RNAs and ribosomes to the cytosol. It is a tightly controlled process that regulates gene expression within a cell.
Proteins targeted to the nucleus carry nuclear localization signals or NLS recognized by import receptors in the cytosol. Similarly, proteins with nuclear export signals are recognized by export receptors. Import and export receptors are...
6.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A special multifiber dietary mixture ameliorates Crohn's-like colitis in an IL-10<sup>-</sup>/<sup>-</sup> mouse model by promoting treg differentiation through the ETS1/RUNX1/Foxp3 axis.

European journal of nutrition·2026
Same author

Sense of Coherence in patients with stable schizophrenia: multidimensional determinants from a cross-sectional study of 438 inpatients in Guangzhou, China.

Frontiers in psychiatry·2026
Same author

Ghost noise in single-fiber bidirectional transmission links and its suppression approaches.

Communications engineering·2026
Same author

Good Practices for Simulation Studies Published in <i>The Journal of Physical Chemistry B</i>.

The journal of physical chemistry. B·2026
Same author

Integrated Protein Precipitation-Solid-Phase Extraction Workflow for Deep Top-Down Proteomic Analysis of Human Serum.

Journal of proteome research·2026
Same author

H<sub>2</sub>O<sub>2</sub>-free proximity proteomics for exploring dynamic protein complexes in living systems.

Nature chemical biology·2026

Related Experiment Video

Updated: Dec 25, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.5K

Small-Molecule Antagonist Targeting Exportin-1 via Rational Structure-Based Discovery.

Xibao Tian1, Jiali Gao1, Meishuo Liu1

  • 1Laboratoy of Innovative Drug Discovery, School of Bioengineering, Dalian University of Technology, Dalian 116023, China.

Journal of Medicinal Chemistry
|April 1, 2020
PubMed
Summary

A novel small molecule, LFS-829, targets exportin-1 to effectively treat colitis in mice. This compound shows promise for colitis treatment with minimal toxicity, suggesting potential clinical applications.

More Related Videos

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
10:51

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists

Published on: November 15, 2013

13.1K
High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels
10:07

High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels

Published on: January 27, 2013

15.5K

Related Experiment Videos

Last Updated: Dec 25, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.5K
Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
10:51

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists

Published on: November 15, 2013

13.1K
High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels
10:07

High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels

Published on: January 27, 2013

15.5K

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Immunology

Background:

  • Exportin-1 (CRM1) is implicated in autoimmune disorders like colitis.
  • Targeting exportin-1 presents a potential therapeutic strategy for colitis.

Purpose of the Study:

  • To discover and characterize a novel small-molecule antagonist of exportin-1.
  • To evaluate the therapeutic potential of LFS-829 in a colitis model.

Main Methods:

  • Structure-based drug design and discovery of LFS-829.
  • Co-crystallography, SPR binding assays, and cell-based functional assays to validate target engagement.
  • In vivo efficacy studies in a mouse model of colitis.

Main Results:

  • LFS-829 demonstrated low nanomolar activity against exportin-1.
  • Target engagement was confirmed via structural and functional assays.
  • Oral administration of LFS-829 reversed colitis pathology by modulating NF-κB and Nrf2 pathways.
  • LFS-829 exhibited a low risk of cardiotoxicity and acute toxicity.

Conclusions:

  • LFS-829 is a potent and selective exportin-1 antagonist with therapeutic potential for colitis.
  • The compound's mechanism involves dual inhibition of NF-κB and activation of Nrf2 pathways.
  • LFS-829 shows promise for clinical translation in treating colitis.